| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Outline of Final Research Achievements |
The number of patients with non-alcoholic steatohepatitis is glowing with the westernization of life in our country. Although progression from non-alcoholic steatohepatitis to the development of liver cirrhosis and liver cancer is a concerning issue, the cause has not been clarified and the treatment has not been established. In this study, we investigated the role of microRNAs, a small non-coding RNA that is not translated into proteins of about, in the formation of non-alcoholic steatohepatitis. It became clear that microRNAs could have important roles in the development of non-alcoholic steatohepatitis.
|
